Subscribe for the newsletter
Articles
Expert Interviews
Roundtable
Press Releases
Videos
The Road To Series
Market Research
Thought Leaders
More
Discovery
Small Molecules
Biologics
Advanced Therapies
Manufacturing
Supply Chain
Clinical Trials
Technologies
Financing
NeuClone
Sort By
Newest First
Sign in
1 / 1
Preclinical Results
NeuClone Announces Preclinical Results for Stelara® (ustekinumab) Biosimilar Candidate
NeuClone Pty. Ltd
PR-M05-18-NI-052
May 14, 2018
1 / 1
